Corneal Graft

CorneaGen issued product recalls for certain corneal and scleral patch grafts, according to press releases from the FDA.

In this video from the virtual European Society of Cataract and Refractive Surgeons winter meeting, Jorge L. Alió, MD, PhD, speaks about therapies for irregular corneas.

Descemet’s stripping endothelial keratoplasty, Descemet’s membrane endothelial keratoplasty and pre-Descemet’s endothelial keratoplasty have changed the cornea transplant game.

Patients with infectious uveitis are at an increased risk for corneal graft failure compared with patients with noninfectious uveitis, according to a study published in Cornea.

Following the positive results of clinical trials, EndoArt, a polymer film implant designed to adhere to the posterior corneal surface to treat chronic corneal edema, was granted the European CE mark.

When the COVID-19 outbreak started in Italy, new guidelines for tissue and cell donation were promptly issued.

Corneal tissue addition appears to improve visual acuity and topography in patients with severe keratoconus, according to a speaker at the virtual American Academy of Ophthalmology annual meeting.

Re-bubbling a Descemet’s membrane endothelial keratoplasty graft using an in-office slit lamp may be safer than using a surgical scope, according to a presentation at the virtual American Academy of Ophthalmology annual meeting.

Five-year follow-up of patients who underwent Descemet’s membrane endothelial keratoplasty for Fuchs’ dystrophy showed “excellent” outcomes, sustained in the long term in both eyes, according to a study.

At the virtual European Society of Cataract and Refractive Surgeons meeting, Gerd Auffarth, MD, PhD, discusses the potential of the EyeYon EndoArt artificial endothelial layer.